- Home
- AXIL vs PDSB Comparison
AXIL vs PDSB Comparison
Compare AXIL & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | PDSB |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 49.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AXIL | PDSB |
|---|---|---|
| Price | $7.46 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 26.5K | ★ 721.1K |
| Earning Date | 01-08-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $27,664,753.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $43.42 | ★ N/A |
| Revenue Growth | ★ 4.18 | N/A |
| 52 Week Low | $3.96 | $0.70 |
| 52 Week High | $10.75 | $2.20 |
Technical Indicators
Market Signals| Indicator | AXIL | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 55.86 | 56.44 |
| Support Level | $7.02 | $0.92 |
| Resistance Level | $7.93 | $1.02 |
| Average True Range (ATR) | 0.64 | 0.09 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 75.44 | 55.26 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.